Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.897,00
0,01%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ vTv Therapeutics Inc (VTVT) vTv Therapeutics Inc (VTVT) Notizie

vTv Therapeutics Inc

VTVT
23,63
-0,0699 (-0,29%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/3/202413:30PRNUSCANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA..
13/3/202413:00GLOBEvTv Therapeutics Announces 2023 Fourth Quarter and Full Year..
07/3/202422:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/3/202401:52EDGAR2Form SC 13D - General statement of acquisition of beneficial..
05/3/202414:04EDGAR2Form 8-K - Current report
04/3/202414:00GLOBEvTv Therapeutics Announces FDA Submission for First Phase 3..
01/3/202414:00GLOBEvTv Therapeutics to Participate at the TD Cowen 44th Annual..
28/2/202415:26EDGAR2Form 8-K - Current report
28/2/202415:14EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/2/202414:08EDGAR2Form 8-K - Current report
28/2/202414:00GLOBEvTv Therapeutics Announces $51 Million Private Placement..
22/2/202422:00PRNUSCANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO &..
22/12/202322:26EDGAR2Form 8-K - Current report
19/12/202322:28EDGAR2Form 8-K - Current report
12/12/202322:21EDGAR2Form 8-K - Current report
20/11/202322:23EDGAR2Form 8-K - Current report
15/11/202314:22EDGAR2Form 8-K - Current report
15/11/202314:19EDGAR2Form 8-K - Current report
09/11/202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:30GLOBEvTv Therapeutics Announces 2023 Third Quarter Financial..
09/11/202322:20EDGAR2Form 8-K - Current report
08/11/202314:00GLOBEvTv Therapeutics to Participate at the Stifel 2023..
02/11/202313:00GLOBEvTv Therapeutics Appoints Thomas Strack, M.D., as Chief..
01/11/202313:24EDGAR2Form 8-K - Current report
01/11/202313:00GLOBEvTv Therapeutics Announces Sale of Shares in Reneo..
27/9/202314:30PRNUSCANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A..
26/9/202314:30PRNUSCantex and Allegheny Health Network Announce Initiation of a..
25/9/202322:20EDGAR2Form DEF 14C - Other definitive information statements
18/9/202314:30PRNUSCANTEX PHARMACEUTICALS AND LENOX HILL HOSPITAL ANNOUNCE..
15/9/202322:17EDGAR2Form PRE 14C - Other preliminary information statements
11/8/202322:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202322:36EDGAR2Form 8-K - Current report
11/8/202322:30GLOBEvTv Therapeutics Announces 2023 Second Quarter Financial..
10/8/202314:33PRNUSCantex Pharmaceuticals Announces Article Published in npj..
20/7/202322:22EDGAR2Form 8-K - Current report
16/6/202314:00GLOBEvTv Therapeutics Partner Cantex Pharmaceuticals Licenses..
15/6/202313:33PRNUSCANTEX PHARMACEUTICALS TO PRESENT AT THE MEDINVEST ONCOLOGY..
24/5/202315:00GLOBEvTv Therapeutics Announces Issuance of U.S. Patent for..
11/5/202322:15GLOBEvTv Therapeutics Announces 2023 First Quarter Financial..
Apertura: 22,85 Min: 22,5001 Max: 24,33
Chiusura: 23,6999

La tua Cronologia

NASDAQ
VTVT
vTv Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network